Clinical trialNCT01435187CompletedObservational

Prematurity and Respiratory Outcomes Program (PROP)

SponsorUniversity of PennsylvaniaEnrollment835PrematurityRespiratory Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

In survivors of extreme prematurity to 36 weeks Post Menstrual Age (PMA), specific biologic, physiologic and clinical data obtained during the initial hospitalization will predict respiratory morbidity as defined by respiratory health care utilization and respiratory symptoms, between discharge and 1 year corrected age. This protocol describes a collaboratively developed multicenter study of very preterm infants from birth through the time of discharge from the Neonatal Intensive Care Unit (NICU) and up to 1 year of age, corrected for the degree of prematurity.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Aaron Hamvas, MD
Washington University School of Medicine / St. Louis Children's Hospital
Principal Investigator
clinicaltrials.gov ↗
Alan H Jobe, MD, PhD
Cincinnati Childrens Hospital
Principal Investigator
clinicaltrials.gov ↗
Barbara K Schmidt, MD
University of Pennsylvania
Principal Investigator
clinicaltrials.gov ↗
Gloria S Pryhuber, MD
University of Rochester
Principal Investigator
clinicaltrials.gov ↗
Jonas H Ellenberg, PhD
University of Pennsylvania
Principal Investigator
clinicaltrials.gov ↗
Judith Voynow, MD
Duke University
Principal Investigator
clinicaltrials.gov ↗
Judy Aschner, MD
Vanderbilt University School of Medicine
Principal Investigator
clinicaltrials.gov ↗
Roberta L Keller, MD
University of California San Francisco/Benioff Children's Hospital
Principal Investigator
clinicaltrials.gov ↗
Stephanie D Davis, MD
Indiana University/Riley Hospital for Children
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Alta Bates Summit Medical Center
Oakland, California, United States
University of California, San Francisco
San Francisco, California, United States
Indiana University Health/riley Hospital for Children
Indianapolis, Indiana, United States
Washington Universitiy
St Louis, Missouri, United States
University of Buffalo
Buffalo, New York, United States
University of Rochester
Rochester, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
Cincinnati University Hospital
Cincinnati, Ohio, United States
Good Samaritan Hospital
Cincinnati, Ohio, United States
Jackson-Madison County General Hospital
Jackson, Tennessee, United States
Monroe Carell Jr Children'S Hospital at Vanderbilt
Nashville, Tennessee, United States
University of Texas, Houston
Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Aug 2011
Primary completion: 30 Apr 2015
Completion: 31 Mar 2016
Last update posted: 7 Nov 2016
Registered enrollment: 835
Registry id: NCT01435187

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.